Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study

Peer Review reports

Original Submission
15 Sep 2022	Submitted	Original manuscript
29 Sep 2022	Reviewed	Reviewer Report
30 Sep 2022	Reviewed	Reviewer Report - Jr-wei Wu
31 Oct 2022	Author responded	Author comments - Piero Barbanti
Resubmission - Version 2
31 Oct 2022	Submitted	Manuscript version 2
Publishing
2 Nov 2022	Editorially accepted
2 Dec 2022	Article published	10.1186/s10194-022-01521-w

Back to article page